Abstract:Objective:To investigate the effect of Roux-en-Y gastric bypass (RYGB) on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetes mellitus (T2DM) rats.Methods:A total of 16 Sprague-Dawley male rats were fed on a high-fat diet and injected intraperitoneally with streptozotocin to induce T2DM, then all rats were randomly divided into sham surgery group ( n=8) and RYGB group ( n=8). RYGB surgery was performed in RYGB group, sham surgeries involved the same gastrointestinal transections as those in the RYGB group, and re-anastomosis was performed at the same sites. Fasting blood glucose levels and food intake were measured before and 1st, 2nd, 4th, 6th, 8th week after surgery. Oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed preoperatively and at 2nd and 8th week postoperatively. At 8th week postoperatively, the fasting serum bile acids levels were measured and hepatic tissues were taken to compare the mRNA expression of farnesoid X receptor (FXR), small heterodimeric partner (SHP), phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) by reverse transcriptase-polymerase chain reaction. Results:At 4th, 6th, 8th week postoperatively, the food intake in RYGB group [(18±2), (19±3), (20±4) g/d] was decreased as compared with sham surgery group [(24±3), (28±4), (26±3) g/d]; At 2nd, 4th, 6th and 8th week postoperatively, the fasting blood glucose levels in RYGB group [(6.9±0.9), (6.0±1.1), (6.4±0.8), (6.8±0.7) mmol/L] were decreased as compared with sham surgery group [(12.9±1.4), (10.8±0.8), (9.4±1.1), (9.0±1.0) mmol/L], with significant differences ( t=4.707, 5.091, 3.394, 9.209, 9.982, 6.239, 5.098, P<0.05); On postoperative week 2, the areas under the curve of OGTT and ITT in RYGB group [(898±118), (428±85) mmol/ (L·min)] were decreased compared with sham surgery group [(1 508±108), (788±98) mmol/ (L·min)]; On postoperative week 8, the areas under the curve of OGTT and ITT in RYGB group [(975±102), (455±76) mmol/ (L·min) ] were decreased as compared with sham surgery group [(1 575±96), (775±86) mmol/ (L·min) ], with significant differences ( t=10.790, 7.849, 12.120, 7.886, P<0.05); On postoperative week 8, the serum total bile acids level in RYGB group [(105.17±14.81) μmol/L] was increased as compared with sham surgery group [(68.87±10.81) μmol/L], with significant differences ( t=5.600, P<0.05); As compared with sham surgery group, the hepatic mRNA expression of FXR and SHP in RYGB group was up-regulated (1.67±0.31 vs. 1.17±0.11, 2.37±0.21 vs. 1.33±0.18), the hepatic mRNA expression of PEPCK and G6Pase in RYGB group was down-regulated (0.77±0.12 vs. 1.15±0.14, 0.87±0.08 vs. 1.05±0.10), with significant differences ( t=4.299, 10.640, 5.829, 3.976, P<0.05). Conclusion:RYGB can improve the glucose metabolism in T2DM rats, which may be related with increased hepatic bile acids signaling and decreased gluconeogenesis.

Duodenal-jejunal bypass improves hypothalamic oxidative stress and inflammation in diabetic rats via glucagon-like peptide 1-mediated Nrf2/HO-1 signaling

Duodenal–Jejunal Bypass Improves Glucose Homeostasis in Association with Decreased Proinflammatory Response and Activation of JNK in the Liver and Adipose Tissue in a T2DM Rat Model

2010-P: Increasing POMC Positive Neurons and Ameliorating the Brain Inflammation Played an Important Role in DJB Improving Glucose Homeostasis in Diabetic Rats

1806-P: Improvement Brain Insulin Signaling in Antidiabetic Effect of Duodenal Jejunal Bypass Surgery

Duodenal-jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve oxidative stress diabetic cardiomyopathy

Duodenal-jejunal bypass increases intraduodenal bile acids and upregulates duodenal SIRT1 expression in high-fat diet and streptozotocin-induced diabetic rats

The Improvement of Type 2 Diabetes by DJB Is related to the Improvement of Intestinal Glucose Sensing and Glucose Transportation

Duodenal-jejunal Exclusion Improves Insulin Resistance in Type 2 Diabetic Rats by Upregulating the Hepatic Insulin Signaling Pathway

Duodenal‐jejunal bypass surgery activates eNOS and enhances antioxidant system by activating AMPK pathway to improve heart oxidative stress in diabetic cardiomyopathy rats

Growth hormone improves insulin resistance in visceral adipose tissue after duodenal-jejunal bypass by regulating adiponectin secretion

Duodenum Exclusion Alone Is Sufficient to Improve Glucose Metabolism in STZ-Induced Diabetes Rats

Preserve Common Limb in Duodenal–Jejunal Bypass Surgery Benefits Rats with Type 2-Like Diabetes

Duodenal-Jejunal Bypass Restores Sweet Taste Receptor-Mediated Glucose Sensing and Absorption in Diabetic Rats

Gastric Bypass Surgery Reverses Diabetic Phenotypes in Bdnf-Deficient Mice

Relief of diabetes by duodenal-jejunal bypass sleeve implantation in the high-fat diet and streptozotocin-induced diabetic rat model is associated with an increase in GLP-1 levels and the number of GLP-1-positive cells.

The Role Of Gut Microbiota In Duodenal-Jejunal Bypass Surgery-Induced Improvement Of Hepatic Steatosis In Hfd-Fed Rats

Protective Effects of Bariatric Surgery on Kidney Functions by Inhibiting Oxidative Stress Responses Through Activating PPARα in Rats With Diabetes

Duodenal-jejunal bypass reduces serum ceramides via inhibiting intestinal bile acid-farnesoid X receptor pathway

Improvements of Glucose and Lipid Metabolism After Jejuno-ileal Circuit Procedure in a Non-obese Diabetic Rat Model

Effect of Roux-en-Y gastric bypass on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetic rats

Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1.